发明名称 AVOIDING NARCOLEPSY RISK IN INFLUENZA VACCINES
摘要 The invention provides influenza vaccines and methods which improve the safety of influenza vaccines further, in particular in relation to the risk of causing narcolepsy in adjuvanted vaccines.
申请公布号 US2014335116(A1) 申请公布日期 2014.11.13
申请号 US201414275373 申请日期 2014.05.12
申请人 NOVARTIS AG 发明人 Ahmed Syed Sohail;Steinman Lawrence;Volkmuth Wayne
分类号 C07K14/005;C12N7/00;G01N33/569 主分类号 C07K14/005
代理机构 代理人
主权项 1. An influenza vaccine composition comprising influenza virus A nucleoprotein wherein a fragment of said nucleoprotein equivalent to amino acids 106 to 126 of SEQ ID NO: 2 binds to an MHC class II receptor comprising HLA DQB1*0602 with a lower affinity than a peptide having the amino acid sequence shown in SEQ ID NO:1, with the proviso that if all influenza A nucleoprotein in the composition comprises the amino acid sequence shown in SEQ ID NO: 12, then the vaccine composition is not based on strain A/California/7/2009 (H1N1)-derived strain NYMC X-181.
地址 Basel CH
您可能感兴趣的专利